Suspected Prostate Cancer
Conditions
Interventions
None listed
Sponsors
Juntendo University, Graduate School of Medicine
Juntendo University Nerima Hospital, Graduate School of Medicine Nippon Medical School, Graduate School of Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Male patients aged 18 years or older at the time of obtaining consent. Male patients suspected of having prostate cancer, with PSA test results meeting the following criteria (based on prostate cancer guidelines): Aged 50 to 65 years: PSA level of 3.0 ng/mL or higher Aged 65 to 70 years: PSA level of 3.5 ng/mL or higher Other age groups: PSA level of 4.0 ng/mL or higher Patients scheduled for a prostate biopsy due to suspicion of prostate cancer. Individuals who have been adequately informed about the study, have a sufficient understanding, and have provided written consent of their own free will to participate in this study.
Exclusion criteria
Exclusion criteria: Patients under 20 years of age at the time of obtaining consent. Dialysis patients. Patients who have had a urinary tract infection requiring antibiotic treatment within 6 weeks prior to urine collection. Patients who have had a Foley catheter or cystoscope inserted within 6 weeks prior to urine collection. Patients who have undergone a digital rectal examination within 7 days prior to urine collection. Patients who have used 5-alpha reductase inhibitors within 6 months prior to urine collection. Patients who refuse to consent or are unable to consent to this study. Others deemed unsuitable as study subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ROC Curve AUC for the PURE Index | — |
Countries
Japan
Contacts
Public ContactYoshihiro Ikehata
Juntendo University, Graduate School of Medicine Department of Urology
Outcome results
None listed